Roivant Sciences Ltd. · NASDAQ:ROIV
Venker Eric sold 200,000 Roivant Sciences Ltd. shares (Form 4)
Traded May 20 to May 22, 2026 · Filed May 22, 2026
From May 20 to May 22, 2026, Venker Eric (President & Immunovant CEO) sold 200,000 Roivant Sciences Ltd. shares at US$30.27 for US$6.05M under a trading plan, leaving 1,613,063 shares. Filed May 22, 2026 (Form 4).
- Sold
- 200,000 shares
- Price
- US$30.27
- Value
- US$6.05M
- Holding after
- 1,613,063 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- President & Immunovant CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 20, 2026 | Common Shares | Shares withheld for tax | 34,483 | US$32.41 | 1,613,063 | Direct |
| May 22, 2026 | Common Shares | Option exercise | 200,000 | US$3.85 | 1,813,063 | Direct |
| May 22, 2026 | Common Shares | Sale | 200,000 | US$30.27 | 1,613,063 | Direct |
Source
Related
- Roivant Sciences Ltd.
- Venker Eric
- Roivant Sciences Ltd. shareholders
- Form 4 · Venker Eric · Oct 2, 2026
- Form 4 · Venker Eric · Sep 1, 2026
- Form 4 · Venker Eric · Aug 24, 2026
- Form 4 · Venker Eric · Jul 29, 2026
- Form 4 · Venker Eric · Jun 26, 2026
- Form 4 · Epperly Melissa B, · Oct 5, 2026
- Form 4 · Gline Matthew · Oct 2, 2026
- Form 4 · Sukhatme Mayukh · Oct 2, 2026
- Form 4 · Torti Frank · Oct 2, 2026
- Form 4 · Pulik Richard · Sep 22, 2026